Asunto(s)
Antibacterianos , Farmacorresistencia Bacteriana , Clima , Cambio Climático , Calentamiento Global , HumanosAsunto(s)
Infecciones por Coronavirus/epidemiología , Reglamento Sanitario Internacional/normas , Neumonía Viral/epidemiología , Betacoronavirus , COVID-19 , Infecciones por Coronavirus/economía , Salud Global , Humanos , Pandemias/economía , Neumonía Viral/economía , Salud Pública , SARS-CoV-2 , Organización Mundial de la SaludAsunto(s)
Infecciones por Coronavirus/prevención & control , Reglamento Sanitario Internacional , Derecho Internacional , Pandemias/prevención & control , Neumonía Viral/prevención & control , Viaje/legislación & jurisprudencia , COVID-19 , Infecciones por Coronavirus/epidemiología , Salud Global/legislación & jurisprudencia , Humanos , Neumonía Viral/epidemiología , Organización Mundial de la SaludAsunto(s)
Salud Global/legislación & jurisprudencia , Política de Salud , Accesibilidad a los Servicios de Salud/legislación & jurisprudencia , Desarrollo Sostenible/legislación & jurisprudencia , Femenino , Salud Global/economía , Salud Global/historia , Equidad en Salud/normas , Equidad en Salud/tendencias , Accesibilidad a los Servicios de Salud/economía , Accesibilidad a los Servicios de Salud/organización & administración , Historia del Siglo XXI , Humanos , Servicios Legales/métodos , Esperanza de Vida/tendencias , Masculino , Control Social Formal/métodos , Personas Transgénero/legislación & jurisprudenciaRESUMEN
The World Health Organization (WHO) was born as a normative agency and has looked to global health law to structure collective action to realize global health with justice. Framed by its constitutional authority to act as the directing and coordinating authority on international health, WHO has long been seen as the central actor in the development and implementation of global health law. However, WHO has faced challenges in advancing law to prevent disease and promote health over the past 75 years, with global health law constrained by new health actors, shifting normative frameworks, and soft law diplomacy. These challenges were exacerbated amid the COVID-19 pandemic, as states neglected international legal commitments in national health responses. Yet, global health law reforms are now underway to strengthen WHO governance, signaling a return to lawmaking for global health. Looking back on WHO's 75th anniversary, this article examines the central importance of global health law under WHO governance, reviewing the past successes, missed opportunities, and future hopes for WHO. For WHO to meet its constitutional authority to become the normative agency it was born to be, we offer five proposals to reestablish a WHO fit for purpose: normative instruments, equity and human rights mainstreaming, sustainable financing, One Health, and good governance. Drawing from past struggles, these reforms will require further efforts to revitalize hard law authorities in global health, strengthen WHO leadership across the global governance landscape, uphold equity and rights at the center of global health law, and expand negotiations in global health diplomacy.
RESUMEN
Negotiations ought not focus on enforcement and sanctions.
Asunto(s)
Cooperación Internacional , Derecho Internacional , Pandemias , Pandemias/legislación & jurisprudencia , Pandemias/prevención & control , Cooperación Internacional/legislación & jurisprudencia , Organización Mundial de la Salud , HumanosRESUMEN
The COVID-19 pandemic has shown the need for better global governance of pandemic prevention, preparedness, and response (PPR) and has emphasised the importance of organised knowledge production and uptake. In this Health Policy, we assess the potential values and risks of establishing an Intergovernmental Panel for One Health (IPOH). Similar to the Intergovernmental Panel on Climate Change, an IPOH would facilitate knowledge uptake in policy making via a multisectoral approach, and hence support the addressing of infectious disease emergence and re-emergence at the human-animal-environment interface. The potential benefits to pandemic PPR include a clear, unified, and authoritative voice from the scientific community, support to help donors and institutions to prioritise their investments, evidence-based policies for implementation, and guidance on defragmenting the global health system. Potential risks include a scope not encompassing all pandemic origins, unclear efficacy in fostering knowledge uptake by policy makers, potentially inadequate speed in facilitating response efforts, and coordination challenges among an already dense set of stakeholders. We recommend weighing these factors when designing institutional reforms for a more effective global health system.